Medoc develops and manufactures neurodiagnostic medical systems used to assess and monitor acute and chronic pain. The company's products are based on technologies that test and evaluate the function of small and large peripheral sensory nerve fibers.
Medoc's product lines deliver noninvasive, painless diagnosis and assessment capabilities for research and clinical environments. They are based on the commercialization of quantitative sensory testing techniques and technologies and are integrated into user-friendly, easy-to-operate, cost-effective systems that can be used in many disciplines.
In addition, the company's patented rapid pain stimulation technology has facilitated new developments such as functional MRI, pharmaceutical research, and other pain-related treatments and testing modalities in specific medical and research fields.
All the company's products are FDA approved, certified by CSA, and CE marked to the EN-60601-1 International Safety Standard.
In 2007, Medoc decided to expand its activities by exclusively representing international companies and their products in the Israeli market. The company established a new in-house division to manage the new commerce activities in Israel.
